FDA Alert: Angiotensin Receptor Blockers (ARBs): Ongoing Safety Review for Cancer Risk
Links shared publicly online about this topic.
- 1,019total visits
FDA Alert: Angiotensin Receptor Blockers (ARBs): Ongoing Safety Review for Cancer Risk
View full resource at drugs.com
Most Recently Shared on July 16, 2010 at 12:22 am By:
FDA Alert - Angiotensin Receptor Blockers: Ongoing Safety Review for Cancer Risk - http://bit.ly/b2MJfG
Medical News: ARB Cancer Risk Under FDA Review - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “One month after a meta-analysis suggested angiotensin receptor blockers (ARBs) for hypertension may increase cancer risk, the FDA has announced a formal safety review.” View full resource at medpagetoday.com
Most Recently Shared on July 17, 2010 at 2:24 pm By:
The Kidney Group Physician Group and Nephrology
ARB Cancer Risk Under FDA Reviewhttp://www.medpagetoday.com/Nephrology/Hypertension/21189
Medical News: ARB Cancer Risk Under FDA Review - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “One month after a meta-analysis suggested angiotensin receptor blockers (ARBs) for hypertension may increase cancer risk, the FDA has announced a formal safety review.” View full resource at medpagetoday.com
Most Recently Shared on July 15, 2010 at 8:55 pm By:
Patricia Grace Eldercare Expert
ARB Cancer Risk Under FDA Review: One month after a meta-analysis suggested angiotensin receptor blockers (ARBs) f... http://bit.ly/cYc7xY
Advertisement
